Skip to Main Content
Woman doctor pointing at a DNA Helix

2nd Biennial Miami Precision Medicine

May 4-5, 2024
The Diplomat Beach Hotel - Hollywood, FL


Unlocking the Future of Healthcare:
Join Us at the Miami Precision Medicine Conference!

Join us at the 2nd Biannual Miami Precision Medicine Conference to immerse yourself in the latest advancements in precision oncology.
Learn from renowned experts and patient advocates, shaping the future of cancer care.


The 2nd Biennial Miami Precision Medicine (MPM) 2024 conference will bring together diverse experts in the field to share their knowledge and approaches in moving the precision medicine field towards routine practice. Precision Oncology- treating the right patient with the right treatment at the right time- has made substantial progress in developing novel and effective treatments that target specific molecular alterations in an increasing number of cancer types. The course will examine the treatment landscape based on published and emerging data.

The conference will also illustrate the role of Artificial Intelligence (AI) in identifying patterns and innovative strategies for specific cancers and individual patient populations. An interdisciplinary molecular tumor board case discussion will emphasize the role of germline and genomic alterations in selecting targeted treatments as well as present relevant precision medicine clinical trials.

The success of next-generation precision oncology depends not only on the discovery of new actionable disease characteristics and the integration of multi-omic data, but also on the dissemination of clinical information amongst healthcare providers and the ability of patients to access novel targeted anticancer therapies not only locally, but globally.

Patients and advocacy groups will have an opportunity to “sit at the table” and share their insight, learn about promising clinical trials and partner with physicians to develop new strategies tailored to their specific needs.

The conference’s goal is to promote and facilitate awareness, education and equity in precision medicine cancer care and ultimately to identify and overcome barriers to precision medicine.


At the conclusion of this activity, learners will be able to:

  • Expedite adoption of germline and genomic testing in clinical practice
  • Interpret next generation sequencing (NGS) results
  • Interpret results of a liquid biopsy (ctDNA)
  • Explain the role of multi-omics in precision oncology
  • Summarize role of biomarkers in selection of targeted therapies and immunotherapies in different cancer types
  • Recognize the emerging role of Artificial Intelligence in precision medicine
  • Describe common molecular alterations and the role of molecular diagnostic tests in different cancer types
  • Summarize recent and emerging data from key studies in clinical and translational cancer research
  • Implement strategies designed to improve the quality of cancer care, address barriers to optimal care and enhance the patient experience
  • Identify the role of lifestyle intervention in the precision medicine care model
  • Identify the role of scentific advances in the field of cancer biology and tumor pathogenesis
  • Develop collaborations that will lead to improved clinical trial portfolio and clinical trial participation
  • Interact with patients and patient advocacy groups to promote access to molecularly-driven therapies and available clinical trials
  • Facilitate patient-oncology experts’ interaction and understanding of survivorship challenges in the era of precision medicine

Target Audience


Family Medicine General Surgery Gynecology-Oncology Hematology Hospice and Palliative Medicine Integrative Medicine Internal Medicine Neuro-Oncology Neurosurgery Obstetrics and Gynecology Oncology Pain Management Pathology Pediatric Oncology Physical Medicine and Rehabilitation Preventive Medicine Radiation Oncology Surgical Oncology Thoracic Surgery Transplant Urologic Oncology


Allied Health Care Professional Dietitian Fellow Medical Student Nurse, Nurse Practitioner Pharmacist Physician Physician Assistant Researcher Resident Scientist Technologist

Presented by:

Sylvester Comprehensive Cancer Center and NCI logos

Sponsored by:

University of Miami Miller School of Medicine